General Information of Drug (ID: DMJ6NO8)

Drug Name
HBV-002
Indication
Disease Entry ICD 11 Status REF
West nile virus infection 1D46 Phase 1 [1]
Cross-matching ID
TTD ID
D09NQX

References

1 ClinicalTrials.gov (NCT00707642) Safety Study of HBV-002 West Nile Vaccine in Healthy Adults. U.S. National Institutes of Health.